| Literature DB >> 35897887 |
Mohamed Ksila1,2, Anne Vejux1, Emmanuelle Prost-Camus3, Philippe Durand3, Imen Ghzaiel1,4, Thomas Nury1, Dorian Duprey5, Smail Meziane4, Olfa Masmoudi-Kouki2, Norbert Latruffe1, Taoufik Ghrairi2, Michel Prost3, Gérard Lizard1, Dominique Vervandier-Fasseur5.
Abstract
Trans-resveratrol is a natural polyphenol showing numerous biological properties, especially anti-tumoral and antioxidant activity. Among numerous resveratrol derivatives, aza-stilbenes, which bear an imine bound, show interesting biological activities. In the present study, we synthesized a series of imine analogs of trans-resveratrol (seven aza-stilbenes) following an easy and low-cost procedure of green chemistry. The toxicity of synthesized aza-stilbenes, which is currently unknown, was evaluated on murine neuronal N2a cells, comparatively to trans-resveratrol, by considering: cell density evaluated by staining with sulforhodamine 101; esterase activity, which is a criteria of cell viability, by staining with fluorescein diacetate; and transmembrane mitochondrial potential, which is known to decrease during cell death, by staining with DiOC6(3) using flow cytometry. In addition, the antioxidant activity was quantified with the KRL (Kit Radicaux Libres) assay, the DPPH (2,2'-diphenyl-1-picrylhydrazyl radical) assay and the FRAP (ferric reducing antioxidant power) assay. The PAOT (Pouvoir Antioxidant Total) score was also used. The aza-stilbenes provide different cytotoxic and antioxidant activities, which are either higher or lower than those of trans-resveratrol. Based on their cytotoxic and antioxidant characteristics, all synthesized aza-stilbenes are distinguished from trans-resveratrol.Entities:
Keywords: antioxidant activity; aza-stilbenes synthesis; cytotoxicity; murine neuronal N2a cells; trans-resveratrol
Mesh:
Substances:
Year: 2022 PMID: 35897887 PMCID: PMC9332718 DOI: 10.3390/molecules27154713
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Structure of trans-resveratrol RSV, aza-stilbenes AZA-ST and azo-stilbenes AZO-ST.
Figure 2Structure of aza-stilbenes 1a–1g.
Scheme 1Synthetic methods for obtaining aza-stilbenes AZA-ST.
Scheme 2Synthesis of AZA-ST 1a–g.
Figure 3Evaluation with the sulforhodamine 101 (SR101) assay of the effects of resveratrol and aza-stilbenes 1a to 1g on cell density. N2a cells were incubated for 48 h with or without resveratrol or aza-stilbenes 1a to 1g in a range of concentrations from 1.5 to 100 µM. Cell density evaluated with SR101 reflects the quantity of adherent cells. The dotted red line makes it possible to evaluate the value of the concentration or the range of concentrations reducing the number of adherent cells by 50% (IC50). Data are the mean ± SD of two independent experiments performed in triplicate. Significance of the differences between control (untreated cells), Resveratrol (trans-resveratrol) or aza-stilbenes 1a to 1g–treated cells; Student’s t test: * p < 0.05 or less.
Figure 4Evaluation with the fluorescein diacetate (FDA) assay of the effects of resveratrol and aza-stilbenes 1a to 1g on cell viability. N2a cells were incubated for 48 h with or without resveratrol or aza-stilbenes 1a to 1g in a range of concentrations from 1.5 to 100 µM. The dotted red line makes it possible to evaluate the value of the concentration, or the range of concentrations, reducing cell viability by 50% (IC50). Data are the mean ± SD of two independent experiments performed in triplicate. Significance of the differences between control (untreated cells), Resveratrol (trans-resveratrol) or aza-stilbenes 1a to 1g–treated cells; Student’s t test: * p < 0.05 or less.
Figure 5Flow cytometric evaluation of transmembrane mitochondrial potential (ΔΨm) with DiOC6(3) under treatment with resveratrol and aza-stilbenes 1a to 1g. N2a cells were incubated for 48 h with or without resveratrol or aza-stilbenes 1a to 1g in a range of concentrations from 1.5 to 100 µM. Data are the mean ± SD of two independent experiments performed in triplicate. Significance of the differences between control (untreated cells), Resveratrol (trans-resveratrol) or aza-stilbenes 1a to 1g–treated cells; Student’s t test: * p < 0.05 or less.
IC50 values of resveratrol and aza-stilbenes 1a to 1g obtained with the SR101, FDA et DiOC6(3) assays. Sulforhodamine 101 (SR101, evaluation of cell density), fluorescein diacetate (FDA, esterase activity/evaluation of cell viability) and DiOC6(3) (measurement of transmembrane mitochondrial potential (ΔΨm)). Aza-stilbenes were compared with resveratrol (trans-resveratrol).
| Molecular | Molecular Weight | IC50 µM | IC50 µM | IC50 µM | |
|---|---|---|---|---|---|
| Resveratrol | C14H12O3 | 228.24 | ~12.5 | 6.25 < IC50 < 12.5 | 100 |
| Aza-Stilbene 1a | C13H11NO2 | 213.228 | 25 < IC50 < 50 | 12.5 | 50 < IC50 < 100 |
| Aza-Stilbene 1b | C13H11NO2 | 213.228 | 12.5 | 12.5 < IC50 < 25 | 50 < IC50 < 100 |
| Aza-Stilbene 1c | C13H11NO2 | 213.228 | 25 | 12.5 < IC50 < 25 | 50 < IC50 < 100 |
| Aza-Stilbene 1d | C13H11NO3 | 229.228 | 25 | 6.25 | 50 < IC50 < 100 |
| Aza-Stilbene 1e | C13H10NOBr | 227.254 | 25 < IC50 < 50 | 6.25 < IC50 < 12.5 | 50 < IC50 < 100 |
| Aza-Stilbene 1f | C13H10NOBr | 276.11 | 25 < IC50 < 50 | 12.5 | 50 < IC50 < 100 |
| Aza-Stilbene1g | C13H10NOBr | 276.11 | 6.25 | ~12.5 | 50 < IC50 < 100 |
Figure 6Quantification of the antioxidant activity of resveratrol and aza-stilbenes 1a to 1g with the KRL test.
Antioxidant activities of resveratrol and aza-stilbenes.
| Antioxidant Activities of Resveratrol and Aza-Stilbenes 1a–1g | ||||
|---|---|---|---|---|
| Compounds | KRL | DPPH | FRAP | PAOT Score |
| Resveratrol | 72.81 ± 1.10 | 32.76 ± 6.40 | 10.41 ± 0.05 | 19.39 ± 1.06 |
| Aza-stilbene 1a | 129.74 ± 3.92 | 35.07 ± 1.75 | 10.52 ± 0.05 | 42.65 ± 0.78 |
| Aza-stilbene 1b | 141.29 ± 4.65 | 38.84 ± 1.90 | 10.02 ± 0.04 | 34.11 ± 0.18 |
| Aza-stilbene 1c | 128.38 ± 2.03 | 5.51 ± 2.25 | 12.32 ± 0.06 | 13.34 ± 0.54 |
| Aza-stilbene 1d | 154.63 ± 3.50 | 47.84 ± 2.35 | 11.05 ± 0.07 | 56.49 ± 0.59 |
| Aza-stilbene 1e | 116.06 ± 4.40 | 48.55 ± 2.40 | 10.34 ± 0.05 | ND |
| Aza-stilbene 1f | 123.78 ± 5.16 | 53.69 ± 2.65 | 10.41 ± 0.05 | ND |
| Aza-stilbene 1g | 125.76 ± 3.39 | 17.23 ± 0.85 | 10.18 ± 0.04 | ND |
Aza-stilbenes and resveratrol were used either at 20 or 25 µM. No differences were observed between resveratrol and aza-stilbenes with the FRAP assays. According to the KRL assay, DPPH assay and PAOT, various antioxidant properties of aza-stilbenes and resveratrol were identified. The KRL assay is expressed as increase of haemolysis time (% of control); DPPH assay: % inhibition; FRAP assay: µMol Fe2+ reduced per mM of resveratrol and aza-stilbenes; PAOT score: (PAOT Score/L) of analyzed sample. Data are means of 1–2 independent experiments realized in triplicate. N.D: not determined.
Figure 7Symbolism for analysis of NMR data.